# Study of BSF 208075 Evaluating Exercise Capacity in Patients With Pulmonary Arterial Hypertension

> **NCT00046319** · PHASE2 · COMPLETED · sponsor: **Gilead Sciences** · enrollment: 60 (—)

## Conditions studied

- Pulmonary Hypertension

## Interventions

- **DRUG:** BSF 208075

## Key facts

- **NCT ID:** NCT00046319
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-09
- **Primary completion:** —
- **Final completion:** 2003-06
- **Target enrollment:** 60 (—)
- **Last updated:** 2009-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00046319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00046319, "Study of BSF 208075 Evaluating Exercise Capacity in Patients With Pulmonary Arterial Hypertension". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00046319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*